ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial
Circulation · 02.01.2024 · 149 (1) · 36-47
DOI: 10.1161/circulationaha.123.066680 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 02.01.2024. Verfasst von Aish Sinha und 15 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre at the School of Cardiovascular M…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Microvascular Angina, Myocardial Ischemia. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council.
Abstract (Originalsprache)
BACKGROUND: Angina with nonobstructive coronary arteries is a common condition for which no effective treatment has been established. We hypothesized that the measurement of coronary flow reserve (CFR) allows identification of patients with angina with nonobstructive coronary arteries who would benefit from anti-ischemic therapy. METHODS: Patients with angina with nonobstructive coronary arteries underwent blinded invasive CFR measurement and were randomly assigned to receive 4 weeks of amlodipine or ranolazine. After a 1-week washout, they crossed over to the other drug for 4 weeks; final assessment was after the cessation of study medication for another 4 weeks. The primary outcome was change in treadmill exercise time, and the secondary outcome was change in Seattle Angina Questionnaire summary score in response to anti-ischemic therapy. Analysis was on a per protocol basis according to the following classification: coronary microvascular disease (CMD group) if CFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre at the School of Cardiovascular Medicine and Sciences (A.S., H.R., O.M.D., U.D., H.E., A.M.S., A.C., M.…
- Department of Medical Statistics, School of Life Course & Population Sciences (A.D.), King's College London, UK.
- Guys' and St. Thomas' NHS Foundation Trust, London, UK (K.D.S., B.C., I.W., A.G., P.P., A.J.W., D.P.).
- King's College Hospital NHS Foundation Trust, London. UK (I.W., A.M.S.).
ORCID-Profile: Haseeb Rahman, Abdel Douiri, Kalpa De Silva, Brian Clapp, Utkarsh Dutta, Howard Ellis, Ajay M Shah, Amedeo Chiribiri, Divaka Perera
Förderung
- British Heart Foundation
- Medical Research Council
Zitieren
APA
Sinha, A., Rahman, H., Douiri, A., Demir, O. M., De Silva, K., Clapp, B., Webb, I., Gulati, A., Pinho, P., Dutta, U., Ellis, H., Shah, A. M., Chiribiri, A., Marber, M., Webb, A. J., & Perera, D. (2024). ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial. Circulation, 149(1), 36-47. https://doi.org/10.1161/circulationaha.123.066680
Vancouver
Sinha A, Rahman H, Douiri A, Demir OM, De Silva K, Clapp B, et al. ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial. Circulation. 2024;149(1):36-47. doi:10.1161/circulationaha.123.066680
BibTeX
@article{Sinha2024,
author = {Sinha, Aish and Rahman, Haseeb and Douiri, Abdel and Demir, Ozan M and De Silva, Kalpa and Clapp, Brian and Webb, Ian and Gulati, Ankur and Pinho, Pedro and Dutta, Utkarsh and Ellis, Howard and Shah, Ajay M and Chiribiri, Amedeo and Marber, Michael and Webb, Andrew J and Perera, Divaka},
title = {ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial},
journal = {Circulation},
year = {2024},
volume = {149},
number = {1},
pages = {36--47},
doi = {10.1161/circulationaha.123.066680}
}
EUVIMED